StonvexLoading…
StonvexStonvexStonvexCore line items from TDOC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $613.85M | $2.53B | $1.89B | $1.26B |
Operating Income | $-61.77M | $-262.95M | $-226.96M | $-175.00M |
Net Income | $-63.84M | $-200.32M | $-175.18M | $-125.67M |
EPS (Diluted) | $-0.36 | $-1.14 | $-1.00 | $-0.72 |
Total Assets | $2.81B | $2.86B | $2.88B | $2.89B |
Total Liabilities | $1.47B | $1.47B | $1.49B | $1.47B |
Cash & Equivalents | $750.74M | $781.08M | $726.25M | $679.62M |
Free Cash Flow OCF − CapEx | $7.86M | $285.46M | $200.34M | $103.36M |
Shares Outstanding | 180.43M | 178.32M | 177.35M | 176.61M |